Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Pharmacotherapy
|
May 1, 1996
New pharmacologic approaches to acute spinal cord injury
D H Rhoney, M S Luer, M Hughes, et al.
Neurological Research
|
August 1, 1995
Modified solution for filling MRI coordinate indicators for the ZD stereotactic frame
M S Alp, M S Luer, M Misra, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
June 1, 2000
Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes
R T Scheife, G T Schumock, A Burstein, et al.
Acta Neurochirurgica
|
January 1, 1995
Transcranial cerebral oximetry and carotid cavernous fistula occlusion. Technical note
M Dujovny, K V Slavin, M S Luer, et al.
The Annals of Pharmacotherapy
|
May 1, 1997
Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes
J H Fischer, M J Cwik, M S Luer, et al.
Neurosurgery
|
May 1, 1995
Regional cerebral oxygen saturation during intra-arterial papaverine therapy for vasospasm: case report
M S Luer, M Dujovny, K V Slavin, et al.
Neurological Research
|
September 24, 1999
Saturable transport of gabapentin at the blood-brain barrier
M S Luer, C Hamani, M Dujovny, et al.
AJNR. American Journal of Neuroradiology
|
September 1, 1995
Use of transcranial cerebral oximetry to monitor regional cerebral oxygen saturation during neuroendovascular procedures
G Hernandez-Avila, M Dujovny, K V Slavin, et al.
Neurosurgical Focus
|
May 15, 1997
Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a Phase II safety and efficacy trial
J Hatton, R P Rapp, K A Kudsk, et al.
Journal of Neurosurgery
|
May 1, 1997
Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a phase II safety and efficacy trial
J Hatton, R P Rapp, K A Kudsk, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Pharmacotherapy
|
May 1, 1996
New pharmacologic approaches to acute spinal cord injury
D H Rhoney, M S Luer, M Hughes, et al.
Neurological Research
|
August 1, 1995
Modified solution for filling MRI coordinate indicators for the ZD stereotactic frame
M S Alp, M S Luer, M Misra, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
June 1, 2000
Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes
R T Scheife, G T Schumock, A Burstein, et al.
Acta Neurochirurgica
|
January 1, 1995
Transcranial cerebral oximetry and carotid cavernous fistula occlusion. Technical note
M Dujovny, K V Slavin, M S Luer, et al.
The Annals of Pharmacotherapy
|
May 1, 1997
Stability of fosphenytoin sodium with intravenous solutions in glass bottles, polyvinyl chloride bags, and polypropylene syringes
J H Fischer, M J Cwik, M S Luer, et al.
Neurosurgery
|
May 1, 1995
Regional cerebral oxygen saturation during intra-arterial papaverine therapy for vasospasm: case report
M S Luer, M Dujovny, K V Slavin, et al.
Neurological Research
|
September 24, 1999
Saturable transport of gabapentin at the blood-brain barrier
M S Luer, C Hamani, M Dujovny, et al.
AJNR. American Journal of Neuroradiology
|
September 1, 1995
Use of transcranial cerebral oximetry to monitor regional cerebral oxygen saturation during neuroendovascular procedures
G Hernandez-Avila, M Dujovny, K V Slavin, et al.
Neurosurgical Focus
|
May 15, 1997
Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a Phase II safety and efficacy trial
J Hatton, R P Rapp, K A Kudsk, et al.
Journal of Neurosurgery
|
May 1, 1997
Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: a phase II safety and efficacy trial
J Hatton, R P Rapp, K A Kudsk, et al.
Page
of 2